| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 22.714 | 23.757 | 25.245 | 25.558 | 27.570 | 37.375 | 77.643 | 85.534 | 80.614 | 81.087 |
| Total Income - EUR | 22.960 | 23.814 | 25.332 | 30.558 | 27.570 | 37.526 | 77.643 | 85.534 | 80.667 | 81.918 |
| Total Expenses - EUR | 10.176 | 7.432 | 6.360 | 9.396 | 16.237 | 22.311 | 29.121 | 32.477 | 37.926 | 36.476 |
| Gross Profit/Loss - EUR | 12.784 | 16.383 | 18.973 | 21.162 | 11.332 | 15.215 | 48.522 | 53.057 | 42.741 | 45.442 |
| Net Profit/Loss - EUR | 12.095 | 15.668 | 18.213 | 20.245 | 10.505 | 14.725 | 47.746 | 52.219 | 41.951 | 42.985 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Soranus Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 13.393 | 8.112 | 4.941 | 70.778 | 57.254 | 45.158 | 34.050 | 19.022 | 39.907 | 24.463 |
| Current Assets | 42.498 | 13.576 | 34.486 | 43.651 | 30.672 | 50.909 | 15.342 | 46.405 | 16.532 | 75.334 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 1.123 | 4 | 0 | 0 | 0 |
| Receivables | 0 | 1.955 | 732 | 1.001 | 982 | 41 | 92 | 38.837 | 145 | 144 |
| Cash | 42.498 | 11.621 | 33.754 | 42.650 | 29.690 | 49.745 | 15.245 | 7.567 | 16.387 | 75.190 |
| Shareholders Funds | 55.437 | 21.316 | 39.168 | 58.695 | 68.063 | 81.498 | 48.703 | 52.267 | 55.608 | 98.282 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 454 | 372 | 259 | 55.735 | 19.863 | 14.570 | 689 | 13.159 | 831 | 1.515 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8610
|
|||||||||
Comments - Soranus Med Srl